94. 原発性硬化性胆管炎 Primary sclerosing cholangitis Clinical trials / Disease details

臨床試験数 : 142 / 薬物数 : 113 - (DrugBank : 37) / 標的遺伝子数 : 19 - 標的パスウェイ数 : 139

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000021411	2016/04/01	01/04/2016	clinical efficacy of oral administration of metronidazolein the treatment of primary sclerosing chol ...	clinical efficacy of oral administration of metronidazolein the treatment of primary sclerosing chol ...	primary sclerosing cholangitis	Patients take metronidazole 250mg orally three times day for 3 weeks.	Keio University, School of Medicine	NULL	Complete: follow-up complete	16years-old	Not applicable	Male and Female	20	Not applicable	Japan
2	NCT03069976 (ClinicalTrials.gov)	January 2016	28/2/2017	Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Identification With Antibiotics ...	Overlap Syndrome and PSC: Evaluating Role of Gut Microflora and Its Modification With Antibiotics in ...	Primary Sclerosing Cholangitis;Autoimmune Hepatitis;Overlap Syndrome	Drug: Metronidazole	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	NULL	Recruiting	3 Years	25 Years	All	20	N/A	Belgium
3	NCT01085760 (ClinicalTrials.gov)	February 2010	10/3/2010	A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis	A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	Drug: Vancomycin;Drug: Metronidazole	Mayo Clinic	PSC Partners Seeking a Cure Foundation	Completed	18 Years	75 Years	All	35	Phase 1	United States

First Previous1Next Last